4.7 Article

Prognostic role of slow vital capacity in amyotrophic lateral sclerosis

Related references

Note: Only part of the references are listed.
Article Clinical Neurology

Regional spreading of symptoms at diagnosis as a prognostic marker in amyotrophic lateral sclerosis: a population-based study

Umberto Manera et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2020)

Article Clinical Neurology

SVC Is a Marker of Respiratory Decline Function, Similar to FVC , in Patients With ALS

Susana Pinto et al.

FRONTIERS IN NEUROLOGY (2019)

Article Clinical Neurology

Refining eligibility criteria for amyotrophic lateral sclerosis clinical trials

Ruben P. A. van Eijk et al.

NEUROLOGY (2019)

Article Clinical Neurology

Prevalence of sleep apnoea and capnographic detection of nocturnal hypoventilation in amyotrophic lateral sclerosis

Matthias Boentert et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2018)

Article Clinical Neurology

Relationships between slow vital capacity and measures of respiratory function on the ALSFRS-R

Carlayne Jackson et al.

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration (2018)

Review Medicine, General & Internal

Amyotrophic lateral sclerosis

Michael A. van Es et al.

LANCET (2017)

Article Clinical Neurology

Comparison of slow and forced vital capacities on ability to predict survival in ALS

Susana Pinto et al.

AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2017)

Article Clinical Neurology

Ability of pulmonary function decline to predict death in amyotrophic lateral sclerosis patients

Irina Enache et al.

AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2017)

Article Respiratory System

Diagnostic methods to assess inspiratory and expiratory muscle strength

Pedro Caruso et al.

JORNAL BRASILEIRO DE PNEUMOLOGIA (2015)

Article Clinical Neurology

Session 1 Joint Opening Session

[Anonymous]

AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2015)

Article Clinical Neurology

The R of ALSFRS-R: Does it really mirror functional respiratory involvement in amyotrophic lateral sclerosis?

Susana Pinto et al.

AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2015)

Article Clinical Neurology

A phase II-III trial of olesoxime in subjects with amyotrophic lateral sclerosis

T. Lenglet et al.

EUROPEAN JOURNAL OF NEUROLOGY (2014)

Article Clinical Neurology

Phrenic nerve studies predict survival in amyotrophic lateral sclerosis

Susana Pinto et al.

CLINICAL NEUROPHYSIOLOGY (2012)

Article Clinical Neurology

Use of respiratory function tests to predict survival in amyotrophic lateral sclerosis

Fusun Baumann et al.

AMYOTROPHIC LATERAL SCLEROSIS (2010)

Article Clinical Neurology

Forced vital capacity (FVC) as an indicator of survival and disease progression in an ALS clinic population

A Czaplinski et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2006)

Article Critical Care Medicine

Use of sniff nasal-inspiratory force to predict survival in amyotrophic lateral sclerosis

RK Morgan et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2005)

Article Clinical Neurology

The ALSFRSr predicts survival time in an ALS clinic population

P Kaufmann et al.

NEUROLOGY (2005)

Article Clinical Neurology

Functional outcome measures as clinical trial endpoints in ALS

BJ Traynor et al.

NEUROLOGY (2004)

Article Clinical Neurology

Disease progression in amyotrophic lateral sclerosis: Predictors of survival

T Magnus et al.

MUSCLE & NERVE (2002)